Open AccessApelin as a new therapeutic target for COVID-19 treatment
Author(s) -
Jihwan Park,
Minhan Park,
Yongsoo Kim,
Yong Cheol Jun,
UiLyong Lee,
ChangMyung Oh
Publication year - 2022
Publication title -
qjm
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.427
H-Index - 118
eISSN - 1460-2725
pISSN - 1460-2393
DOI - 10.1093/qjmed/hcac229
Subject(s) - apelin , receptor , angiotensin converting enzyme 2 , transcriptome , biology , cell culture , cell , fusion protein , endogeny , microbiology and biotechnology , virology , covid-19 , gene , gene expression , biochemistry , medicine , recombinant dna , genetics , infectious disease (medical specialty) , disease
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom